(Total Views: 1240)
Posted On: 04/12/2019 11:35:40 AM
Post# of 93
$OPK News Article - OPKO Reports Additional Oxyntomodulin, OPK-88003, Results From Phase 2 Diabetes and Obesity Trial https://marketwirenews.com/news-releases/opko...90554.html
(0)
(0)
My Twitter: WhyteStocks
Scroll down for more posts ▼
